The top 5 highest-paid women biopharma executives in 2017
The wide gender gap higher up, though improved in recent years, persists in biopharma: Women only hold a quarter of all C-suite level jobs, and less than 15% joined the board of directors. When they do make it to the top, women are overall paid less compared to their male counterparts. Here, FiercePharma lists the top 5 highest-paid female biopharma executives based on their 2017 compensation calculated by Gen:
1. Sandra Peterson
Group Worldwide Chair, Johnson & Johnson
$17.18 million
2. Martine Rothblatt
CEO, United Therapeutics
$16.48 million
3. Laura Schumacher
EVP of External Affairs, General Counsel, and Corporate Secretary, AbbVie
$14.98 million
4. Heather Bresch
CEO, Mylan
$12.74 million
5. Maria Teresa Hilado
Former CFO, Allergan
$10.76 million
